An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen-Reference-Cited by-同舟云学术

An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen

Published:2009-08-01 Issue:3 Volume:125 Page:639-648
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Cappello Paola,Tomaino Barbara,Chiarle Roberto,Ceruti Patrizia,Novarino Anna,Castagnoli Carlotta,Migliorini Paola,Perconti Giovanni,Giallongo Agata,Milella Michele,Monsurrò Vladia,Barbi Stefano,Scarpa Aldo,Nisticò Paola,Giovarelli Mirella,Novelli Francesco

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Immunotherapy for pancreatic cancer - science driving clinical progress;Laheru;Nat Rev Cancer,2005

2. Are oncoantigens suitable targets for anti-tumour therapy?;Cavallo;Nat Rev Cancer,2007

3. Cancer immunotherapy: moving beyond current vaccines;Rosenberg;Nat Med,2004

4. The three Es of cancer immunoediting;Dunn;Annu Rev Immunol,2004

5. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity;Smyth;Adv Immunol,2006

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Representing core gene expression activity relationships using the latent structure implicit in Bayesian networks;Bioinformatics;2024-07-25

2. PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer;Journal of Experimental & Clinical Cancer Research;2024-06-01

3. Non-mutational neoantigens in disease;Nature Immunology;2024-01

4. Metabolite-Based Biosignature of Pancreatic Cancer;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024

5. Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers;Molecular Therapy - Oncolytics;2023-12